Techne Corp., which makes products for the research and diagnostic markets, is buying U.K.-based Tocris for $124 million. ... Techne Corp. buys Tocris Holdings Ltd. for $124 million ...

Bio-Techne will host an earnings conference call today, February 5, 2025, at 8:00 a.m. CST. To listen, please dial 1-877-407-9208 or 1-201-493-6784 (for international callers), and reference ...

Shares of Bio-Techne (NASDAQ:TECH) traded sharply lower in the early premarket trading on Wednesday after KeyBanc Capital Markets downgraded the stock, arguing that the life sciences firm is ...

Techne said today it will acquire Bionostics and its holding company for $104 million cash, in a deal allowing the maker of biotechnology products and hematology controls to expand its offerings ...

Asset Management One Co. Ltd. lifted its stake in Bio-Techne Corp (NASDAQ:TECH - Free Report) by 12.8% during the first ...

Techne has been infected with a plague of negative earnings surprises. The company has posted only one positive surprise in the last seven quarters and has seen earnings estimates decline.

Bio-Techne on Wednesday beat Wall Street estimates for third-quarter profit, driven by growth in its unit that provides proteins, antibodies and other products for research and said it is ...

Discounted cash flows, as well as a peer review, have shown Bio-Techne to be overpriced by approximately $175 per share. Learn more about TECH stock here.

In previous years, Bio-Techne has received weak shareholder support for the executive compensation plan. Last year, 62% of shareholders supported the plan, and the year before only 55% cast yes votes.

GAAP Earnings Results. GAAP EPS was $0.14 per diluted share, versus $0.31 in the same quarter last year. GAAP operating income for the third quarter of fiscal 2025 decreased 42% to $38.7 million ...